Utility of human relevant preclinical animal models in navigating NAFLD to MAFLD paradigm

Fatty liver disease is an emerging contributor to disease burden worldwide. The past decades of work established the heterogeneous nature of non-alcoholic fatty liver disease (NAFLD) etiology and systemic contributions to the pathogenesis of the disease. This called for the proposal of a redefinitio...

Full description

Saved in:
Bibliographic Details
Main Authors: Chua, Damien, Low, Zun Siong, Cheam, Guoxiang, Ng, Aik Seng, Tan, Nguan Soon
Other Authors: School of Biological Sciences
Format: Article
Language:English
Published: 2023
Subjects:
Online Access:https://hdl.handle.net/10356/168555
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-168555
record_format dspace
spelling sg-ntu-dr.10356-1685552023-06-05T15:31:54Z Utility of human relevant preclinical animal models in navigating NAFLD to MAFLD paradigm Chua, Damien Low, Zun Siong Cheam, Guoxiang Ng, Aik Seng Tan, Nguan Soon School of Biological Sciences Lee Kong Chian School of Medicine (LKCMedicine) Science::Biological sciences Nonalcoholic Fatty Liver Disease Nonalcoholic Steatohepatitis Fatty liver disease is an emerging contributor to disease burden worldwide. The past decades of work established the heterogeneous nature of non-alcoholic fatty liver disease (NAFLD) etiology and systemic contributions to the pathogenesis of the disease. This called for the proposal of a redefinition in 2020 to that of metabolic dysfunction-associated fatty liver disease (MAFLD) to better reflect the current understanding of the disease. To date, several clinical cohort studies comparing NAFLD and MAFLD hint at the relevancy of the new nomenclature in enriching for patients with more severe hepatic injury and extrahepatic comorbidities. However, the underlying systemic pathogenesis is still not fully understood. Preclinical animal models have been imperative in elucidating key biological mechanisms in various contexts, including intrahepatic disease progression, interorgan crosstalk and systemic dysregulation. Furthermore, they are integral in developing novel therapeutics against MAFLD. However, substantial contextual variabilities exist across different models due to the lack of standardization in several aspects. As such, it is crucial to understand the strengths and weaknesses of existing models to better align them to the human condition. In this review, we consolidate the implications arising from the change in nomenclature and summarize MAFLD pathogenesis. Subsequently, we provide an updated evaluation of existing MAFLD preclinical models in alignment with the new definitions and perspectives to improve their translational relevance. Ministry of Education (MOE) Published version This work is supported by Singapore Ministry of Education under its Singapore Ministry of Education Academic Research Fund Tier 1 (RG30/20) (N.S.T.). 2023-06-05T07:54:49Z 2023-06-05T07:54:49Z 2022 Journal Article Chua, D., Low, Z. S., Cheam, G., Ng, A. S. & Tan, N. S. (2022). Utility of human relevant preclinical animal models in navigating NAFLD to MAFLD paradigm. International Journal of Molecular Sciences, 23(23), 14762-. https://dx.doi.org/10.3390/ijms232314762 1661-6596 https://hdl.handle.net/10356/168555 10.3390/ijms232314762 36499091 2-s2.0-85143602198 23 23 14762 en RG30/20 International Journal of Molecular Sciences © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Science::Biological sciences
Nonalcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis
spellingShingle Science::Biological sciences
Nonalcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis
Chua, Damien
Low, Zun Siong
Cheam, Guoxiang
Ng, Aik Seng
Tan, Nguan Soon
Utility of human relevant preclinical animal models in navigating NAFLD to MAFLD paradigm
description Fatty liver disease is an emerging contributor to disease burden worldwide. The past decades of work established the heterogeneous nature of non-alcoholic fatty liver disease (NAFLD) etiology and systemic contributions to the pathogenesis of the disease. This called for the proposal of a redefinition in 2020 to that of metabolic dysfunction-associated fatty liver disease (MAFLD) to better reflect the current understanding of the disease. To date, several clinical cohort studies comparing NAFLD and MAFLD hint at the relevancy of the new nomenclature in enriching for patients with more severe hepatic injury and extrahepatic comorbidities. However, the underlying systemic pathogenesis is still not fully understood. Preclinical animal models have been imperative in elucidating key biological mechanisms in various contexts, including intrahepatic disease progression, interorgan crosstalk and systemic dysregulation. Furthermore, they are integral in developing novel therapeutics against MAFLD. However, substantial contextual variabilities exist across different models due to the lack of standardization in several aspects. As such, it is crucial to understand the strengths and weaknesses of existing models to better align them to the human condition. In this review, we consolidate the implications arising from the change in nomenclature and summarize MAFLD pathogenesis. Subsequently, we provide an updated evaluation of existing MAFLD preclinical models in alignment with the new definitions and perspectives to improve their translational relevance.
author2 School of Biological Sciences
author_facet School of Biological Sciences
Chua, Damien
Low, Zun Siong
Cheam, Guoxiang
Ng, Aik Seng
Tan, Nguan Soon
format Article
author Chua, Damien
Low, Zun Siong
Cheam, Guoxiang
Ng, Aik Seng
Tan, Nguan Soon
author_sort Chua, Damien
title Utility of human relevant preclinical animal models in navigating NAFLD to MAFLD paradigm
title_short Utility of human relevant preclinical animal models in navigating NAFLD to MAFLD paradigm
title_full Utility of human relevant preclinical animal models in navigating NAFLD to MAFLD paradigm
title_fullStr Utility of human relevant preclinical animal models in navigating NAFLD to MAFLD paradigm
title_full_unstemmed Utility of human relevant preclinical animal models in navigating NAFLD to MAFLD paradigm
title_sort utility of human relevant preclinical animal models in navigating nafld to mafld paradigm
publishDate 2023
url https://hdl.handle.net/10356/168555
_version_ 1772827847086309376